Roberto Foà

Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial

Meletios Α. Dimopoulos, Evangelos Terpos, Mario Boccadoro et al. · The Lancet Oncology · 2021 · 327 citations

Medicine, Hematology, Oncology +14

Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma

Franck Morschhauser, Paula Marlton, Umberto Vitolo et al. · Annals of Oncology · 2010 · 144 citations · Full text

Medicine, Hematology, Pharmacology +15

High-Dose Therapy and Autologous Stem Cell Transplantation in First Relapse for Diffuse Large B Cell Lymphoma in the Rituximab Era: An Analysis Based on Data from the European Blood and Marrow Transplantation Registry

Nicolas Mounier, Carmen Canals, Christian Gisselbrecht et al. · Biology of Blood and Marrow Transplantation · 2011 · 117 citations · Full text

Medicine, Immunology, Oncology +15

Increase in Ty Lymphocytes in B‐Cell Chronic Lymphocytic Leukaemia

Daniel Catovsky, F. Lauria, Estela Matutes et al. · British Journal of Haematology · 1981 · 99 citations

Life Sciences, Hematology, Immunology +11

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

Mohamad Mohty, Evangelos Terpos, María‐Victoria Mateos et al. · Clinical Lymphoma Myeloma & Leukemia · 2018 · 89 citations · Full text

Medicine, Hematology, Pharmacoeconomics +14